Orit Markowitz

Orit Markowitz practices at Markowitz Medical in New York, New York.

Orit Markowitz's NPI, 1215121538, was assigned on August 29, 2007. Orit Markowitz graduated from Drexel University College of Medicine/Hahnemann University in 2003. Orit Markowitz holds New York license 240489.

Orit Markowitz's primary practice is Markowitz Medical, at 1150 5th Ave Suite 1a Suite 1a, New York, NY 10128-0724. The practice phone is (347) 881-3392.

Orit Markowitz's primary practice is Markowitz Medical in New York, New York. Orit Markowitz is also affiliated with Tisch Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Orit Markowitz to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Orit Markowitz practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Orit Markowitz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Orit Markowitz is licensed in New York.

CMS data shows 6,162 Medicare services from Orit Markowitz across 24 procedure codes in 2024, for 743 Medicare patients. Medicare paid $376,840 for them. Every service was in an office.

CMS counts 743 Medicare patients who saw Orit Markowitz in 2024. The largest group is 75 to 84, with 319 patients. 75% of them have high cholesterol, and 53% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Orit Markowitz's median patient age at 51, with 65% women.

In 2024, Orit Markowitz wrote 970 Medicare Part D claims for 352 patients. 93% of them were for generic drugs. CMS names the drug for 812 of them, across 18 drugs with 11 or more claims each, at $70,788 in total drug cost. In 2023, CMS named 743 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Orit Markowitz for performance year 2024, reported individually. Orit Markowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,266 procedures of skin biopsy by Orit Markowitz, more than 99% of the clinicians it reports for that procedure.

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Orit Markowitz to 4 clinical trials. Conditions studied include Carcinoma, Basal Cell, Eczema and Psoriasis. Regeneron Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Orit Markowitz that name 5 trials.

CMS Open Payments shows 199 general payments to Orit Markowitz from 36 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 86% of the total. LEO Pharma Inc. paid the most, $25,689. It also lists 51 research payments totaling $806,506 from 2016 to 2025, naming 5 clinical trials.

Orit Markowitz graduated from Drexel University College of Medicine/Hahnemann University in 2003.